Advisory to European business considering stock market floatation in surgical instruments business.

Fund raising support to leading multinational player in medical diagnostic clinical analysers.

Commercial development lead for partnering project for new liquid handling and microfluidic technology at leading UK University.

Clinical trial planning, focus group management and sales and marketing planning for Irish SME with novel fracture management approach.

Commercial appraisal of new technologies in biopharmaceutical quantification and sizing, and novel quality control methods for the freeze drying processes of biopharmaceuticals.

Interim management and strategic appraisal support to  large institution regarding two novel technologies with medical diagnostic, bioprocessing and water quality biotechnology applications.

Advisory to investors considering floatation in US company with new hospital non invasive cardiovascular diagnostic technique.

Commercial development lead for new diagnostic platform technology. Co-ordinated development programmes in human pathogen testing, plant pathogen testing and environmental toxic algae.

Appraisal for German company investing in diagnostics in hormones, proteins and viruses.  Foetal membrane indicator subsequently licensed.

Commercial due diligence for investors in novel device in assisted conception procedures

Development assistance to business with new diagnostic test for pre-eclampsia

Advisory to VC investment syndicate, for further investment   in  OTC diabetic monitoring device spinout. Investment application was successful.

Advisory to investors in non invasive microdialysis blood chemistry diagnostic device.